本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Theravance Biopharma Inc.

17.03
-0.0050-0.03%
成交量:11.66萬
成交額:198.53萬
市值:8.82億
市盈率:16.29
高:17.04
開:17.04
低:17.02
收:17.03
52周最高:21.03
52周最低:13.08
股本:5,182.83萬
流通股本:2,585.69萬
量比:0.51
換手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):1.05
每股收益(LYR):2.06
淨資產收益率:20.91%
總資產收益率:1.33%
市淨率:3.05
市盈率(LYR):8.26

資料載入中...

2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/09/14

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/06

重要事件披露

8-K - Current report
2020/06/25

重要事件披露

8-K - Current report
2020/06/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report